Treatment burden, stress, and coping in the context of social distancing: A qualitative study of patients with diabetes mellitus

Overview

Información sobre este estudio

The purpose of this study is to track the treatment burden experienced by patients living with Type 2 Diabetes Mellitus (T2DM) experience as they work to manage their illness in the context of social distancing measures. 

 

To promote social distancing during the COVID-19 pandemic, health care institutions around the world have rapidly expanded their use of telemedicine to replace in-office appointments where possible.1 For patients with diabetes, who spend considerable time and energy engaging with various components of the health care system,2,3 this unexpected and abrupt transition to virtual health care may signal significant changes to the treatment burden associated with diabetes management.4 Previous research has characterized the effect of telemedicine approaches on outcomes such as glycemic control, patient satisfaction, cost savings, and appointment adherence rates,5-8 but its influence on treatment burden has not been explored. Importantly, work in this area has largely drawn from the experiences of patients who voluntarily selected to use virtual health services. The current situation, in which patients with chronic health conditions have been obligated to use telemedicine in order to receive care, therefore presents a unique opportunity to explore the ways in which virtual diabetes management impacts the workload associated with managing chronic illness.

Aim: Explore patient experiences managing diabetes mellitus in the context of recent widespread changes in healthcare and social distancing due to the novel coronavirus pandemic, including barriers and facilitators to obtaining needed health care services and changes in social networks. To accomplish this aim, we will conduct qualitative interviews with up to 30 participants.

 

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Adult (≥ 18 years old)
  • Diagnosis of diabetes mellitus using insulin pump and/or CGM technology
  • No evidence of cognitive impairment
  • English proficiency
  • Has a contact telephone number listed in patient chart

Exclusion Criteria:

  • Pediatric patients (<18 years old)
  • Not diagnosed with diabetes mellitus
  • Evidence of cognitive impairment, or inability to give consent
  • Limited English proficiency
  • No telephone number listed in patient chart

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Victor Montori, M.D.

Cerrado; inscripción por invitación

¿Qué es esto? (?)
"Close"
El estudio no está abierto para todos los que cumplen con los criterios de elegibilidad, sino solamente para las personas que el equipo del estudio ha invitado a participar.

Contact information:

Elizabeth Golembiewski Ph.D., M.P.H.

(507) 284-1920

Golembiewski.Elizabeth@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20502014

Mayo Clinic Footer